Please provide your email address to receive an email when new articles are posted on . The FDA recently approved the first continuous glucose monitoring system that does not require calibration with ...
Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Abbott ($ABT) reported the latest data for its FreeStyle Libre system that doesn't ...
ABBOTT PARK, Ill., Sept. 27, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the FreeStyle ® Libre Flash Glucose Monitoring System ...